7th Annual Symposium on Clinical and Pharmaceutical Solutions through Analysis.
7th Annual Symposium on Clinical & Pharmaceutical Solutions through Analysis, Renaissance Shanghai Pudong Hotel, Shanghai, China, 20-23 April 2016 The 7th Annual Shanghai Symposium on Innovative Approaches to Reduce Attrition and Predict Clinical Outcomes (CPSA Shanghai 2016) was held on 20-23 April 2016 in Renaissance Shanghai Pudong Hotel, Shanghai, China. The meeting was featured with highly interactive events including diversified symposia, round table discussions, workshops, poster sessions and conference awards. There were over 220 participants from more than ten countries, with 61 oral presentations and 29 posters presented. In addition, the meeting included one preconference workshop and three joint sessions held with bioanalytical experts from local communities.
Frontage Laboratories, No. 13 Building, 67 Libing Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China.
Tianyi Tee
TT
Zhang
Frontage Laboratories, Shanghai, China.
Li
L
Wang
Janssen, Pharmaceutical companies of Johnson & Johnson, USA.
Naidong
N
Weng
GlaxoSmithKine, Shanghai, China.
Kelly
K
Dong
New Objective, Woburn, MA, USA.
Gary
G
Valaskovic
Milestone Development Services, Newtown, PA, USA.
Mike
M
Lee
D015415:Biomarkers / Q000032:analysis*; D002681:China; D002851:Chromatography, High Pressure Liquid; D051544:Cytochrome P-450 CYP3A / Q000378:metabolism; D055808:Drug Discovery; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000378:metabolism; D053719:Tandem Mass Spectrometry
D015415:Biomarkers; D004364:Pharmaceutical Preparations; D051544:Cytochrome P-450 CYP3A
CPSA, drug development; bioanalysis; biomarker; biomolecule; clinical outcome